Your browser doesn't support javascript.
loading
The effect of concomitant use of proton pump inhibitors with CDK 4/6 inhibitors on survival in metastatic breast cancer.
Çaglayan, Dilek; Koçak, Mehmet Zahid; Geredeli, Çaglayan; Tatli, Ali Murat; Göksu, Sema Sezgin; Eryilmaz, Melek Karakurt; Araz, Murat; Artaç, Mehmet.
Afiliação
  • Çaglayan D; Department of Medical Oncology, Meram Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey. dilekcaglayan88@gmail.com.
  • Koçak MZ; Department of Medical Oncology, Meram Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey.
  • Geredeli Ç; Department of Medical Oncology, Okmeydani Training and Research Hospital, Istanbul, Turkey.
  • Tatli AM; Department of Medical Oncology, Faculty of Medicine, Akdeniz University, Antalya, Turkey.
  • Göksu SS; Department of Medical Oncology, Faculty of Medicine, Akdeniz University, Antalya, Turkey.
  • Eryilmaz MK; Department of Medical Oncology, Meram Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey.
  • Araz M; Department of Medical Oncology, Meram Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey.
  • Artaç M; Department of Medical Oncology, Meram Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey.
Eur J Clin Pharmacol ; 79(2): 243-248, 2023 Feb.
Article em En | MEDLINE | ID: mdl-36520173
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Female / Humans Idioma: En Revista: Eur J Clin Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Turquia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Female / Humans Idioma: En Revista: Eur J Clin Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Turquia